Prothena reported $438.89M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Akebia Therapeutics AKBA:US $ 26.12M 50.34M
ALKERMES ALKS:US $ 1075.39M 37.19M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Amgen AMGN:US $ 916M 5784M
Biogen BIIB:US $ 11242.3M 346.1M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Exelixis EXEL:US $ 2293.85M 83.24M
Intercept Pharmaceuticals ICPT:US $ -371.76M 187.8M
Intra Cellular Therapies ITCI:US $ 792.75M 374.86M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Macrogenics MGNX:US $ 178.21M 61.4M
Nektar Therapeutics NKTR:US $ 607.89M 71.62M
Neurocrine Biosciences NBIX:US $ 1391.1M 17.1M
Prothena PRTA:US $ 438.89M 27.16M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Seattle Genetics SGEN:US $ 2998.47M 66.67M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
Vital Therapies VTL:US $ 137.96M 10.85M
Xoma XOMA:US $ 139.92M 1.95M
YTE INCY:US $ 3863.07M 93.07M